GleamWall
中文EN

ARDT Ardent Health, Inc.

Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 1756655 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.0%
TTM net income YoY-28.7%
TTM EPS YoY-30.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin2.3%
FCF margin—
EBITDA margin—

Returns

ROE11.1%
ROA2.8%
ROIC (approx.)—
Asset turnover1.23x

Leverage & solvency

Liabilities / assets66.7%
Debt / equity0.79x
Current ratio2.13x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.30x
Accruals ratio-6.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.62B$1.62B$1.60B$1.61B$1.58B$1.65B$1.50B$1.61B
SG&A expense$42.40M$61.20M$48.60M$36.80M$36.50M$32.60M$34.90M$36.70M
Pretax income$81.03M$43.20M$74.59M$92.37M-$2.20M$121.99M$74.20M$167.25M
Income tax$17.64M$8.51M$16.10M$18.11M-$3.41M$26.29M$15.23M$26.36M
Net income$44.52M$16.90M$39.85M$44.96M-$23.48M$72.95M$41.38M$114.20M
EPS (basic)0.320.120.28—-0.170.520.30—
EPS (diluted)0.310.120.28—-0.170.520.29—
Weighted avg. shares (diluted)141.70M143.05M141.78M—141.23M141.52M140.70M—
Balance sheet
Cash & equivalents$766.24M$724.48M$609.69M$709.60M$609.44M$540.63M$495.04M$556.78M
Receivables$661.85M$695.95M$685.99M$686.10M$729.41M$758.64M$776.52M$743.03M
Inventory$110.10M$116.02M$119.84M$118.59M$121.59M$118.40M$120.36M$115.09M
Current assets$2.17B$2.05B$2.02B$2.06B$1.96B$1.88B$1.76B$1.83B
PP&E, net$899.77M$920.04M$922.81M$935.77M$887.98M$870.38M$856.52M$861.90M
Goodwill$861.86M$879.26M$879.26M$879.45M$877.51M$877.68M$876.59M$852.08M
Intangibles———$12.40M————
Total assets$5.35B$5.28B$5.25B$5.29B$5.15B$5.03B$4.91B$4.96B
Current liabilities$1.02B$976.32M$951.48M$1.05B$943.15M$880.87M$830.14M$945.42M
Short-term debt$28.76M$28.57M$37.63M$23.44M$19.34M$19.33M$17.76M$9.23M
Long-term debt$1.07B$1.07B$1.07B$1.08B$1.09B$1.09B$1.09B$1.09B
Total debt$1.10B$1.10B$1.11B$1.10B$1.11B$1.11B$1.11B$1.10B
Total liabilities$3.57B$3.54B$3.52B$3.61B$3.52B$3.38B$3.35B$3.43B
Shareholders' equity$1.40B$1.35B$1.34B$1.29B$1.24B$1.25B$1.18B$1.13B
Net debt$332.21M$377.31M$500.71M$389.62M$496.92M$569.09M$613.26M$538.27M
Shares outstanding140.93M141.91M143.13M142.86M143.17M143.10M143.04M142.75M
Cash flow statement
Operating cash flow$121.93M$196.74M-$60.22M$223.44M$154.37M$117.49M-$24.79M$119.57M
Investing cash flow-$40.14M-$39.18M-$27.90M-$86.23M-$58.63M-$46.25M-$23.12M-$105.44M
Financing cash flow-$40.03M-$42.77M-$11.79M-$37.05M-$26.93M-$25.66M-$13.83M-$20.48M
Depreciation & amortization$41.06M$41.34M$42.99M$41.04M$39.16M$39.31M$36.20M$37.85M
Share buybacks$10.98M———$0———

Free plan shows the latest 8 periods; Pro shows all 15 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.